ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $573,468 | -50.4% | 36,400 | -93.1% | 0.00% | -50.0% |
| Q2 2019 | $1,156,000 | -67.7% | 527,776 | -11.8% | 0.00% | -85.7% |
| Q1 2019 | $3,583,000 | +26.9% | 598,160 | +56.6% | 0.01% | +16.7% |
| Q4 2018 | $2,823,000 | -49.1% | 381,948 | 0.0% | 0.01% | -40.0% |
| Q3 2018 | $5,546,000 | -27.3% | 381,948 | 0.0% | 0.02% | -31.0% |
| Q2 2018 | $7,628,000 | +47.7% | 381,948 | +29.6% | 0.03% | +38.1% |
| Q1 2018 | $5,163,000 | -20.0% | 294,698 | +12.6% | 0.02% | -16.0% |
| Q4 2017 | $6,455,000 | – | 261,759 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |